EICHORCondition: Osteoarthritis (OA) of the Knee · Sponsor: Orient Europharma Co., Ltd.
This clinical trial is designed to determine safety and tolerability as well as the MTD of a single-dose 2ccPA and PK data in symptomatic knee OA.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Veteran General Hospital Taipei | Taipei, Taiwan | — |
| Tri-Service General Hospital | Taipei, Taiwan | — |
| Mackay Memorial Hospital | Taipei, Taiwan | — |
| Kaohsiung Chang Gung Memorial Hospital | Taipei, Taiwan | — |
| National Cheng Kung University Hospital | Taipei, Taiwan | — |
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04229394